Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the vascular dementia market?

In recent years, the market size for vascular dementia has seen significant growth. The market value is predicted to expand from $2.92 billion in 2024 to $3.27 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.1%. This rapid growth during the historic period can be traced back to factors such as escalating healthcare spending, an increasing count of vascular dementia diagnosis, growth in the number of healthcare professionals, expansion of public health initiatives, and a rising prevalence of diabetes.

What will be the vascular dementia market size in the future?

In the ensuing years, the market size of vascular dementia is projected to witness swift expansion. A target of $5.11 billion is anticipated by 2029, marking a compound annual growth rate (CAGR) of 11.8%. This growth over the forecasted period can be attributed to factors such as increased consciousness about vascular dementia, escalating healthcare investments, a growing elderly population, increased incidences of cardiovascular diseases, and a rising prevalence of high blood pressure. Some of the primary trends to watch out for during the forecast period include technological advancements, bespoke treatment plans, telemedicine, gene therapy, and artificial intelligence.

Get your vascular dementia market report here!

https://www.thebusinessresearchcompany.com/report/vascular-dementia-global-market-report

What main drivers are fueling expansion in the vascular dementia market?

The escalation of cardiovascular disease is anticipated to drive the growth of the vascular dementia market in the future. This term encompasses a range of disorders impacting the heart and blood vessels such as coronary artery disease, heart failure, arrhythmias, and hypertension. The growth of these diseases is motivated by elements like unhealthy living habits, poor nutrition, lack of physical activity, high stress levels, aging demographics, and an upturn in risk factors like obesity, diabetes, and hypertension. Since cardiovascular diseases hinder blood flow to the brain, they increase the risk of vascular dementia by contributing to cognitive deterioration and damage to brain cells due to insufficient oxygen and nutrient availability. For example, data from the British Heart Foundation, a UK-based cardiovascular research charity, revealed in September 2024 that about 7.6 million individuals in the UK suffer from heart and circulatory diseases. Around 4 million males and 3.6 million females are living with these diseases. These conditions account for approximately 27% of total deaths in the UK, amounting to over 170,000 annually, or nearly 480 deaths each day, which means one death every three minutes. Consequently, the escalating cardiovascular diseases prevalence fuels the vascular dementia market.

What key areas define the segmentation of the global vascular dementia market?

The vascular dementia market covered in this report is segmented –

1) By Product: Monoclonal Antibodies, Small Molecules, Peptides

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

3) By End User: Hospitals And Clinics, Rehabilitation Centers, Specialty Clinics

Subsegments:

1) By Monoclonal Antibodies: Anti-Amyloid Monoclonal Antibodies, Anti-Tau Monoclonal Antibodies

2) By Small Molecules: Cholinesterase Inhibitors, Glutamate Modulators, Anti-Inflammatory Small Molecules

3) By Peptides: Amyloid-Beta Targeted Peptides, Neuroprotective Peptides, Tau-Targeting Peptides

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20998&type=smp

Who are the dominant players expanding their reach in the vascular dementia market?

Major companies operating in the vascular dementia market are Intermountain Healthcare Inc., CSPC Ouyi Pharmaceutical Co. Ltd., Duke Health, Massachusetts General Hospital, Emory Healthcare Inc., Apollo Hospitals Enterprise Limited, Amedisys Inc., Northwestern Memorial HealthCare, IBS Hospitals Pvt. Ltd., Resverlogix Corp., ProNeurogen Inc., Cyclerion Therapeutics Inc., Aribio Inc., Pinteon Therapeutics Inc., Dementech Neurosciences Ltd., Moleac Pte. Ltd., Isaac Health Inc., Cadabam’s Group of Hospitals, Alpha Cognition Inc., Citi Health

What are the key trends shaping the future of the vascular dementia market?

Major companies operating in the vascular dementia market are focusing on developing novel therapies, such as multimodal therapies, to sustain their position in the market. Multimodal therapies refer to the integration of various treatment approaches, such as medications, physical therapy, and psychological interventions, to treat a condition comprehensively. For instance, in January 2023, Moleac, a Singapore-based biopharmaceutical company, launched CognivAiD an evidence-based treatment specifically designed for vascular dementia (VaD), a condition with limited therapeutic options. This product combines active extracts from ginkgo, ginseng, and saffron, which have been shown to significantly slow cognitive decline in VaD patients. The unique multimodal action of CognivAiD targets key mechanisms of vascular dementia, including vascular protection, vasoregulation, and neuroinflammation. Supported by extensive clinical trials and a strong safety profile, CognivAiD presents a promising new treatment for individuals suffering from VaD.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20998

Which regions are emerging as leaders in the vascular dementia market?

North America was the largest region in the vascular dementia market in 2024. The regions covered in the vascular dementia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Lewy Body Dementia Treatment Global Market Report 2025

https://thebusinessresearchcompany.com/report/lewy-body-dementia-treatment-global-market-report

Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/anti-vascular-endothelial-growth-factor-therapeutics-global-market-report

Vascular Embolization Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/vascular-embolization-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: